Clinical Trials Browser

Phase 2 × Anthracyclines × 90 days × Clear all

NCT07548710 2026-06-03

Study of SA+X in the Treatment of Newly Diagnosed AML

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute